1. Gilfillan, M. & Bhandari, V. Pulmonary phenotypes of bronchopulmonary dysplasia in the preterm infant. Semin. Perinatol. 47, 151810 (2023).
2. Villamor-Martinez, E. et al. Association of Chorioamnionitis With Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review, Meta-analysis, and Metaregression. JAMA Netw. Open 2, e1914611 (2019).
3. McGoldrick E., Stewart F., Parker R. & Dalziel S. R.: Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst. Rev. 12, CD004454 (2020).
4. Doyle, L. W., Cheong, J. L., Hay, S., Manley, B. J. & Halliday, H. L. Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst. Rev. 10, CD001146 (2021).
5. Doyle, L. W., Cheong, J. L., Ehrenkranz, R. A. & Halliday, H. L. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst. Rev. 10, CD001146 (2017).